Major Drivers Propelling the Growth oh theCancer Supportive Care Products Market Forward: Rising Cancer Incidence Fuels Growth In Supportive Care Products Market
Discover trends, market shifts, and competitive outlooks for the cancer supportive care products industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Cancer Supportive Care Products Market Size from 2025 to 2034?
In recent times, the market size for cancer supportive care products has experienced significant growth. It is projected to climb from $21.56 billion in 2024 to $22.65 billion in 2025, with a compound annual growth rate (CAGR) of 5.1%. This development during the historical period is largely due to rising cancer rates, enhanced awareness and education about the disease, improved healthcare infrastructure, increasing geriatric population, and the emphasis on early detection.
Expectations are that the market size for cancer supportive care products will experience consistent growth in the coming years. By 2029, the market is projected to reach $27.32 billion at a compound annual growth rate (CAGR) of 4.8%. This anticipated growth during the forecast period is largely due to the increasing incidence of cancer, a surge in patient-centric practices, an escalation in funding for cancer research, a growing emphasis on customised medication, and a climb in cancer survival rates. Key trends to look out for in the forecast period comprise of technological advancements, superior drug delivery systems, innovative drug formulas, personalised care, and creation of biodegradable products.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18529&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Cancer Supportive Care Products Market?
The growth of the cancer supportive care products market is anticipated to be driven by the rising incidence of cancer. The risk of cancer tends to grow as individuals age, due to factors such as cellular alterations and extended exposure to risk elements. In addition, habits like smoking, poor nutrition, lack of exercise, and excessive alcohol consumption play a significant role in elevating cancer risk. Cancer supportive care products function to manage symptoms, enhance the quality of life, and provide support for patients in treatment, fulfilling the increasing need brought about by the escalating incidence of cancer. For instance, the American Cancer Society, a U.S.-based non-profit dedicated to cancer eradication, projected in January 2024 that there would be 58,450 occurrences of oral cavity and pharynx cancer, indicating a 7.2% rise from the 54,540 cases documented in 2023. Consequently, the mounting incidence of cancer is predicted to fuel the expansion of the cancer supportive care products market.
Which Key Market Segments Comprise the Cancer Supportive Care Products Market and Drive Its Revenue Growth?
The cancer supportive care products market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor
2) By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies
Subsegments
1) By Nonsteroidal Anti-Inflammatory Drugs (Nsaids): Ibuprofen, Aspirin, Naproxen
2) By Anti-Infective: Antibiotics, Antifungal Drugs, Antiviral Drugs
3) By Anti-Emetics: 5-Ht3 Antagonists (Ondansetron), Nk1 Antagonists (Aprepitant), Corticosteroids (Dexamethasone)
4) By Monoclonal Antibodies: Rituximab, Trastuzumab, Bevacizumab
5) By Erythropoietin Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa
6) By Opioid Analgesics: Morphine, Fentanyl, Oxycodone
7) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate
8) By Granulocyte Colony Stimulating Factor: Filgrastim, Pegfilgrastim
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18529&type=smp
Which Areas Are Leading Regions in the Cancer Supportive Care Products Market Expansion Across the Globe?
North America was the largest region in the cancer supportive care products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Cancer Supportive Care Products Market?
Top firms in the cancer supportive care products market are prioritizing advancements in cancer therapies, such as precision guided radioligand therapy (RLT) to amplify treatment effectiveness, mitigate side effects, and enhance patient prognoses overall. A targeted radioligand therapy (RLT) platform employs radiolabeled molecules that bind explicitly to markers of cancer cells, which delivers localized radiation and selectively destroys only the cancerous cells while leaving healthy tissue intact. For example, in May 2022, Novartis AG, a pharmaceutical corporation headquartered in Switzerland, gained US Food and Drug Administration (FDA) clearance for Pluvicto (lutetium Lu 177 vipivotide tetraxetan), which is used to treat PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) in adults that has spread despite earlier treatments. Pluvicto is the first FDA-sanctioned targeted radioligand therapy (RLT) accessible for suitable mCRPC patients, and it integrates a targeting ligand with a therapeutic radioisotope. The FDA has provided approval for Locametz (gallium Ga 68 gozetotide injection) too, which is utilized in PET scans to identify PSMA-positive lesions, assisting in determining the spread of the cancer and if patients are eligible for treatment with Pluvicto.
View the full report here:
How Is the Cancer Supportive Care Products Market Conceptually Defined?
Cancer supportive care products refer to a range of medical treatments, therapies, and products designed to manage and alleviate the symptoms, side effects, and complications associated with cancer and its treatments. These products aim to improve the quality of life for cancer patients by addressing various aspects of care, including physical, emotional, and psychological support.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18529
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
